MRD / Regn No. : 20260000552 Date : 22/06/2026
Patient Name : Mohanalakshmi Babu Age & Gender : 60 Yrs. / Female
Contact No. : 9941880002 UHID :
Ht / Wt / BMI : BP S / BP D :
Allergies : NKA Referred By :
   
Problem List : TYPE 2 DM (01/Jan/1970) | A2G3 DKD (22/Jun/2026) |
Subjective : DM SINCE AGE 35,RECURRENT UTI,DR,ASCVD,MENOPAUSE AT AGE 43
Objective : NONE
Analysis : TYPE 2 DM,A2G3 DKD
Plan : DIET EXERCISE INSULIN USE AND TITRATION,SEE ME IN 1 MONTH  
Salient Investigations : NT PROBNP : 598.9 pg/mL | FUNDUS GLAUCOMA: AMR | FUNDUS MACULAR DEGENERATION: DR
S# Generic (Trade) Name Route Dosage Usage Duration
1 INJECTION DEGLUDEC / ASPART (INJ U100) 70/30
RYZODEG
Medicine For DIABETES
SQ 24-0-18 UNITS BEFORE FOOD
TILL NEXT VISIT
MAY CAUSE HYPOGLYCEMIA
2 EMPAGLIFLOZIN 10 MG LINAGLIPTIN 5 MG
GLYXAMBI 10/5
1-0-0 BEFORE FOOD
TILL NEXT VISIT
EMPAGLIFLOZIN MAY CAUSE GENITOURINARY INFECTION KEEP GENITAL AREA CLEAN
3 ROSUVASTATIN 10 MG
ROSEDAY 10 MG
Medicine For CHOLESTEROL
PO 0-0-1 AT BEDTIME
TILL NEXT VISIT
MAY CAUSE FATIGUE AND MUSCLE PAIN
4 TELMISARTAN 40 MG
TELMA 40 MG
0-0-1 AT BEDTIME
TILL NEXT VISIT
5 METOPROLOL XL 12.5 MG
PROMET XL 12.5 MG
0-0-1 AT BEDTIME
TILL NEXT VISIT
       
Refill : 0 / Substitution:    
Education : AVOID CONJEE SWEETS CHOCOLATES AND SIMPLE SUGARS OF ANY KIND,AVOID OR REDUCE RESTAURANT FOOD,AVOID PROCESSED FOOD,EXERCISE 150 MINUTES PER WEEK,REDUCE CARBOHYDRATE BY 20%,REDUCE SEDENTARY TIME
Next Visit : 22/Jul/2026
Tests Suggested For Next Visit : FBS 2HPP SMBG
   
   

Dr. Krishna G Seshadri
Sr. Consultant Endocrinology Diabetes and Metabolism
Tamil Nadu / 48748 HPRID: 71-0638-2075-7542

This is a Computer generated Prescription

Powered By: